Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos R Camara-Lemarroy

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Medical Hypotheses|June 21, 2014
Remote ischemic preconditioning as prevention of transfusion-related acute lung injuryCarlos R Camara-Lemarroy
Multiple Sclerosis and Related Disorders|June 29, 2026
Taking progressive biology seriously in the time of B-cells and BTKCarlos R Camara-Lemarroy
Multiple Sclerosis and Related Disorders|November 24, 2024
Multiple Sclerosis and biological definitions in neurodegenerative diseasesCarlos R Camara-Lemarroy
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 23, 2018
Area postrema syndrome: A short history of a pearl in demyelinating diseasesCarlos R Camara-Lemarroy, Jodie M Burton
The Neurohospitalist|September 13, 2023
Prolonged Transient Global Amnesia: Part of the Clinical Spectrum or a Separate Disease Entity?Heather Y F Yong, Carlos R Camara-Lemarroy
American Journal of Clinical Dermatology|August 6, 2013
The role of tumor necrosis factor-α in the pathogenesis of vitiligoCarlos R Camara-Lemarroy, Julio C Salas-Alanis
World Journal of Gastroenterology|October 13, 2018
Focus on the gut-brain axis: Multiple sclerosis, the intestinal barrier and the microbiomeCarlos R Camara-Lemarroy, Luanne M Metz, V Wee Yong
Journal of the Neurological Sciences|September 13, 2014
Gastrointestinal complications after ischemic strokeCarlos R Camara-Lemarroy, Beatriz E Ibarra-Yruegas, Fernando Gongora-Rivera
Multiple Sclerosis and Related Disorders|April 9, 2023
Simple parameters from complete blood count predict lymphopenia, adverse effects and efficacy in people with MS treated with dimethyl fumarateMaria-Elizabeth Baeva, Luanne M Metz, Jamie Greenfield, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 24, 2018
Severe hypertriglyceridemia associated with teriflunomide in a patient with multiple sclerosis: A case reportCarlos R Camara-Lemarroy, Joaquín Castilló, Jaume Sastre-Garriga, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Medical Hypotheses|June 21, 2014
Remote ischemic preconditioning as prevention of transfusion-related acute lung injuryCarlos R Camara-Lemarroy
Multiple Sclerosis and Related Disorders|June 29, 2026
Taking progressive biology seriously in the time of B-cells and BTKCarlos R Camara-Lemarroy
Multiple Sclerosis and Related Disorders|November 24, 2024
Multiple Sclerosis and biological definitions in neurodegenerative diseasesCarlos R Camara-Lemarroy
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 23, 2018
Area postrema syndrome: A short history of a pearl in demyelinating diseasesCarlos R Camara-Lemarroy, Jodie M Burton
The Neurohospitalist|September 13, 2023
Prolonged Transient Global Amnesia: Part of the Clinical Spectrum or a Separate Disease Entity?Heather Y F Yong, Carlos R Camara-Lemarroy
American Journal of Clinical Dermatology|August 6, 2013
The role of tumor necrosis factor-α in the pathogenesis of vitiligoCarlos R Camara-Lemarroy, Julio C Salas-Alanis
World Journal of Gastroenterology|October 13, 2018
Focus on the gut-brain axis: Multiple sclerosis, the intestinal barrier and the microbiomeCarlos R Camara-Lemarroy, Luanne M Metz, V Wee Yong
Journal of the Neurological Sciences|September 13, 2014
Gastrointestinal complications after ischemic strokeCarlos R Camara-Lemarroy, Beatriz E Ibarra-Yruegas, Fernando Gongora-Rivera
Multiple Sclerosis and Related Disorders|April 9, 2023
Simple parameters from complete blood count predict lymphopenia, adverse effects and efficacy in people with MS treated with dimethyl fumarateMaria-Elizabeth Baeva, Luanne M Metz, Jamie Greenfield, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 24, 2018
Severe hypertriglyceridemia associated with teriflunomide in a patient with multiple sclerosis: A case reportCarlos R Camara-Lemarroy, Joaquín Castilló, Jaume Sastre-Garriga, et al.
Pageof 4